Biomarkers

Alzheimers Dement. 2025 Dec;21 Suppl 2:e104478. doi: 10.1002/alz70856_104478.ABSTRACTBACKGROUND: Though previous research supports diffusion tensor imaging (DTI) as a biomarker for white matter integrity in diseases such as Alzheimer's disease/mild cognitive impairment (ADMCI), Parkinson's disease (

D Dana N Broberg

Biomarkers

Alzheimers Dement. 2025 Dec;21 Suppl 2:e103087. doi: 10.1002/alz70856_103087.ABSTRACTBACKGROUND: Latin America (LA) experiences disparities driven by social determinants of health and low socioeconomic status, which increase the risk of dementia. These adverse factors may contribute to dementia thro

N Nickole P Marin-Díaz

Biomarkers

Alzheimers Dement. 2025 Dec;21 Suppl 2:e103352. doi: 10.1002/alz70856_103352.ABSTRACTBACKGROUND: Cerebrovascular disease (CeVD) is a clinically significant disease entity, known to be associated with increased risk of cognitive decline [1]. However, the lack of validated blood biomarkers for CeVD, l

M Ming Ann Sim

Fibrates : Do They Still Have a Role in Therapy in 2025?

Curr Atheroscler Rep. 2025 Dec 26;28(1):4. doi: 10.1007/s11883-025-01379-8.ABSTRACTPURPOSE OF REVIEW: Atherosclerotic cardiovascular disease (ASCVD) remains a leading cause of mortality despite optimal LDL-C control, leaving substantial residual risk in patients with atherogenic dyslipidaemia. This

A Angela Pirillo

Biomarkers

CONCLUSION: ^(18)F-SMBT-1 is a robust surrogate marker of regional reactive astrogliosis. It is highly correlated with Aβ burden and with plasma GFAP. High ^(18)F-SMBT-1 precedes and predicts high Aβ suggesting reactive astrogliosis is an interesting target for early therapeutic interventions.Alzhei

V Victor L Villemagne

Clinical Manifestations

Alzheimers Dement. 2025 Dec;21 Suppl 3:e107780. doi: 10.1002/alz70857_107780.ABSTRACTBACKGROUND: Vascular Cognitive Impairment (VCI) is the second most common cause of dementia after Alzheimer's Disease (AD) (Gorelick et al.,2011). The coexistence of cerebrovascular pathology with AD pathology adds

M Mohammed Adnan Azam

Epigenetics and chemical exposures

Essays Biochem. 2025 Nov 26;69(3):195-197. doi: 10.1042/EBC20253053.ABSTRACTSeminal epidemiological studies led by Barker, Hales and collaborators identifying links between low birth weight and subsequent risk of traditionally adult-onset diseases such as cardiovascular disease and type 2 diabetes l

A Adriana Córdova-Casanova

Biomarkers

Alzheimers Dement. 2025 Dec;21 Suppl 2:e104492. doi: 10.1002/alz70856_104492.ABSTRACTBACKGROUND: Impaired glymphatic clearance has been associated with neurodegenerative diseases causing dementia. The diffusion tensor image analysis along the perivascular space (DTI-ALPS) index has been proposed as

D Daniela Andriuta

Diuretic Response Prediction With MELD Score in Heart Failure

Clin Cardiol. 2025 Dec;48(12):e70245. doi: 10.1002/clc.70245.ABSTRACTBACKGROUND: Heart failure (HF) is still an important disease with high mortality rates worldwide. HF treatment is also difficult due to different phenotypes. Diuretic response (DR) is one of the main differences across these subgro

V Volkan Kozluca

Cardiovascular Risk in Bulgarian Antarctic Expedition Participants

Wilderness Environ Med. 2025 Dec 26:10806032251409144. doi: 10.1177/10806032251409144. Online ahead of print.ABSTRACTIntroductionThe primary objective of this study was to assess cardiovascular risk among members of the Bulgarian Antarctic expedition and identify strategies for risk reduction. The c

A Albena Alexandrova

Drug Development

Alzheimers Dement. 2025 Dec;21 Suppl 5:e107036. doi: 10.1002/alz70859_107036.ABSTRACTBACKGROUND: Oxidative stress (OS) plays a significant role in vascular mild cognitive impairment (vMCI), and the antioxidant N-acetylcysteine (NAC) was proposed to mitigate cognitive decline. However, our randomized

Y Yejin Kang